COVID-19 treatment | DGCI rejects Dr Reddy’s application for full market authorisation for remdesivir: Report

Dr Reddy’s proposal comes after the USFDA granted remdesivir full regulatory status – making it the first COVID-19 drug to receive full approval

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-treatment-|-dgci-rejects-dr-reddy’s-application-for-full-market-authorisation-for-remdesivir-report_14447841.html